Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Biomarkers Market Size, Value And Growth Trajectory Through 2030
The biomarkers market has experienced substantial expansion in recent times. Its value is projected to increase from $77.42 billion in 2025 to $88.42 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 14.2%. The historical growth of this market is attributable to key factors such as advancements in molecular biology, increased pharmaceutical research and development spending, the rising prevalence of cancer, greater utilization in clinical trials, and the demand for targeted therapies.
The biomarkers market is poised for substantial expansion in the upcoming years. It is forecast to reach $150.52 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.2%. This projected expansion over the forecast period stems from factors such as the broadening of personalized treatment approaches, the increasing use of liquid biopsy biomarkers, greater regulatory support for biomarker-based pharmaceuticals, a rise in neurological disease research, and strengthened collaborations between pharmaceutical and diagnostics firms. Noteworthy trends for the forecast period include the expanding application of biomarkers in precision medicine, their increasing integration into drug discovery and development, growing adoption in oncology and chronic disease management, the proliferation of companion diagnostics, and an intensified focus on early disease detection.
Get A Free Sample Report With In-Depth Market Insights:
Biomarkers Market Growth Drivers: What’s Behind The Acceleration?
An escalating prevalence of heart diseases is projected to stimulate the expansion of the biomarkers market throughout the projected period. The application of biomarkers for individuals suffering from heart conditions has seen a substantial rise in recent years. Presently, natriuretic peptides represent the most frequently utilized biomarker, assisting in the diagnosis of heart failure patients. Moreover, biomarkers like circulating biomarkers, including high sensitivity C-reactive protein, are also employed for diagnosing heart failure. In the United States, heart disease stands as a primary cause of mortality across most racial and ethnic demographics. This rise in heart diseases is expected to boost the demand for biomarkers. For example, in September 2025, the British Heart Foundation, a UK-based charity, reported that over 7.6 million people (comprising more than 4 million men and over 3.6 million women) are currently afflicted with cardiovascular disease across the UK. Furthermore, their forecasts suggest that, propelled by an aging population and enhanced survival rates, the number of affected individuals could increase by approximately 1 million by 2030 and by roughly 2 million by 2040. Consequently, the growing incidence of heart diseases is fueling the growth of the biomarkers market.
Biomarkers Market Segments: Where Is Growth Concentrated?
The biomarkers market covered in this report is segmented –
1) By Technology: Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers
2) By Disease: Neurological Diseases, Cancer, Immunological Diseases, Cardiovascular Diseases, Other Diseases
3) By Type: Biomarker Of Exposure, Biomarker Of Diseases
4) By Audiences: Pharmaceutical Companies, Government And Private Research Institutes, Academic Institutes, Medical Device Manufacturing Companies
Subsegments:
1) By Safety Biomarkers: Toxicity Biomarkers, Pharmacokinetic Biomarkers, Adverse Effect Biomarkers
2) By Efficacy Biomarkers: Pharmacodynamic Biomarkers, Disease Progression Biomarkers, Treatment Response Biomarkers
3) By Validation Biomarkers: Analytical Validation Biomarkers, Clinical Validation Biomarkers, Qualification Biomarkers
Biomarkers Market Trends: What’s Defining The Industry’s Next Phase?
Leading companies in the biomarker market are developing innovative offerings, such as biomarker tests, to reach broader customer bases, increase sales, and boost revenue. Biomarker tests, also known as biomarker assays, are laboratory or diagnostic procedures that measure specific biological indicators, including molecules, genes, proteins, or other substances, to provide insights into various physiological or pathological processes within the body. For example, in July 2023, Quest Diagnostics, a US-based medical laboratories company, introduced a novel prostate cancer biomarker test. This newly launched tissue-based test service seeks to fulfill the urgent clinical requirement for tests that can help identify potentially aggressive cases of prostate cancer in males. Quest developed and validated this laboratory test via an intellectual property license agreement with Envision, which allows for the use of Envision’s exclusive biomarker and immunohistochemistry technology, incorporating Envision’s distinct staining methods and innovative biomarkers known as EV1, EV2, and EV3.
Biomarkers Market Key Participants And Competitive Landscape
Major companies operating in the biomarkers market are Enzo Biochem Inc, Bio-Rad Laboratories Inc., Merck KGaA, PerkinElmer Inc., QIAGEN N. V., Adaptive Biotechnologies Corp., Agilent Technologies Inc., Biocrates Life Sciences AG, BioFire Diagnostics LLC, BioReference Laboratories Inc., Bio-Techne Corporation, Cepheid Inc., Eurofins Scientific SE, Exact Sciences Corporation, Foundation Medicine Inc., Genomic Health Inc., GenScript Biotech Corporation, Guardant Health Inc., Illumina Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Luminex Corporation, Metabolon Inc., Myriad Genetics Inc., Natera Inc., Pacific Biosciences of California Inc., Quest Diagnostics Incorporated, Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Veracyte Inc.
View The Full Biomarkers Market Report:
Biomarkers Market Top Region By Revenue And Market Share
North America was the largest region in the biomarkers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model